Bradley Maron: A New Era of Human-Centric Cardiovascular Science
Bradley Maron, Editor-in-Chief of Circulation at American Heart Association, shared a post on LinkedIn about a recent article by Joseph C. Wu, published in Circulation, adding:
”Inside the Journal:
Our commitment to basic and translational sciences at Circulation is anchored by Deputy Editor Dr. Joseph C. Wu — a world-recognized powerhouse scientist in cardiovascular disease.
Joe has pioneered key advances in stem cell biology and drug discovery, and is a leading champion of new approach methodologies (NAMs) — creative alternatives to traditional animal models that aim to accelerate promising discoveries toward real clinical application.
Here’s why it matters: animal models have driven real discoveries, but they don’t fully capture the complexity of human cardiovascular disease.
Joe argues the future belongs to human-centric platforms — iPSC-derived heart cells, genome editing, AI, and single-cell multiomics — used together rather than in isolation.
He points to two emerging frontiers: ‘cell villages,’ where cells from thousands of genetically distinct people are studied side by side to capture real human variation, and ‘clinical trial-in-a-dish,’ testing candidate therapies on human cells before they ever reach a patient.
Check out his Perspective article this week in Circulation, where he provides a window into his vision for foundational sciences at the journal.”
Title: Perspectives on the Future of Fundamental Sciences in Cardiovascular Medicine
Author: Joseph C. Wu
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian